Non-profit Vaccines IAVI is a non-profit focused on translating scientific discoveries into affordable, globally accessible vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases, presenting a unique angle for grant funding partnerships, government collaborations, and philanthropic sponsorships.

Public Health Impact Strategic selling points include IAVI's mission to deliver public health solutions at scale, which aligns with NGOs, international health organizations, and donor programs seeking high-impact, cost-effective vaccine and antibody development.

Tech and Data IAVI employs a mix of analytics and clinical data tools (SAS/STAT, Oracle Clinical) suggesting opportunities to offer data management, analytics, and software integration services to optimize trial design, data workflows, and reporting.

Funding Readiness With modest funding and a relatively small employee base, IAVI may be receptive to partnerships that accelerate programs through grant-writing support, fundraising consulting, or technology-enabled collaboration platforms.

Global Collaboration IAVI’s focus on globally accessible solutions implies potential partnerships with large biopharma partners, contract research organizations, and international bodies for co-development, manufacturing partnerships, or distribution alliances.